By
Drug Target Review2024-03-07T12:00:20
Researchers have developed an algorithm which could improve diagnostics of ovarian high-grade serous carcinoma.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-08T12:00:00Z
2026-07-08T07:58:00Z
Contributor Dr Nick Lynch, By Dr Raminderpal Singh
2026-03-11T14:00:00
Sponsored by Merck
2025-10-22T14:00:00
Sponsored by Wuxi Biologics
2025-11-13T14:00:00
Sponsored by Cell Signaling Technology
2023-09-27T13:56:39
Sponsored by Euretos
2026-06-15T11:00:00
Sponsored by Miltenyi Biotec
2025-09-18T12:00:00
Sponsored by Benchling
Site powered by Webvision Cloud